Printer Friendly

New Partnership Provides Single Source for Cognitive Analysis of Food and Nutrition Products.

CHICAGO -- Cognitive Drug Research, Ltd (CDR) and Provident Clinical Research & Consulting, Inc. (Provident) announced a strategic partnership to provide comprehensive clinical trial services to evaluate the cognitive effects of functional foods, food additives, consumer health products and dietary supplements. The partnership brings together CDR's 25 years of experience as the research industry's leading computerized cognitive assessment provider and Provident's internationally-recognized expertise in providing both consultative and clinical services to the food and consumer health industries.

"This partnership provides a unique opportunity for all types of food, nutrition, dietary supplement and ingredient companies to draw on a single source for consultation, design, implementation and analysis of their products with regard to cognitive function," said Provident President/Chief Science Officer, Kevin C. Maki, PhD. "We have a strong understanding of the goals and objectives of this industry and have structured our organizations to meet those needs."

CDR and Provident have collaborated on a number of successful programs. This non-exclusive partnership will include the designation of Provident's research clinics in Addison, Illinois, and Bloomington, Indiana, as CDR Centres of Excellence. CDR cognitive test systems will be permanently installed on site and Provident's staff will be certified on the proper administration of The CDR System. The companies also plan to develop a series of investigator-initiated projects and participate in joint scientific presentations and publications.

The CDR Centres of Excellence will conduct research necessary to meet Food and Drug Administration and Federal Trade Commission guidance on claims addressing the memory and attention effects of food and nutrition products.

"We recognized significant synergies which could be enhanced through a defined partnership," added CDR Vice President, Steven T. Satek. "Our companies not only possess aligned missions to enhance research and awareness within the consumer health and food industries, but we also possess a strong commitment to quality, scientifically-based research."

About Cognitive Drug Research Ltd

Founded by Professor Keith Wesnes in 1986, Cognitive Drug Research now employs more than 70 staff members in the UK, US and Australia, and is the world's leading provider of automated cognitive function assessment in clinical trials. CDR's proprietary cognitive assessment system can be administered to virtually any patient population in any environment and provides rapid, sensitive and highly reliable assessments of the core domains of cognitive function. The CDR System is used throughout the drug development process, from first-in-man trials to large worldwide Phase IV trials. The CDR System has been used in over 1,000 trials, and is documented to ICH GCP and FDA 21 CFR part 11 standards. www.cdr.us.com

About Provident Clinical Research & Consulting, Inc.

Founded by Dr. Kevin C. Maki in 2004, Provident Clinical Research & Consulting, Inc. employs more than 35 staff members in its three offices (Addison, Illinois; Glen Ellyn, Illinois; Bloomington, Indiana). Provident's mission is to advance the science of chronic disease prevention by designing and conducting clinical trials. In addition to working with CDR on cognitive function research, Provident specializes in designing and conducting trials in clinical nutrition, consumer health and management of risk factors for heart disease and diabetes. Provident hopes to contribute to the development of safe and effective ways to help people live longer, healthier lives. www.providentcrc.com
COPYRIGHT 2009 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

 
Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 19, 2009
Words:529
Previous Article:ConocoPhillips Statement on American Clean Energy and Security Act of 2009.
Next Article:Patrick Brandt Joins Telligent as Chief Executive Officer.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters